These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 9610538)
1. Nitric oxide-induced downregulation of Cdk2 activity and cyclin A gene transcription in vascular smooth muscle cells. Guo K; Andrés V; Walsh K Circulation; 1998 May; 97(20):2066-72. PubMed ID: 9610538 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery. Chen D; Krasinski K; Sylvester A; Chen J; Nisen PD; Andrés V J Clin Invest; 1997 May; 99(10):2334-41. PubMed ID: 9153274 [TBL] [Abstract][Full Text] [Related]
3. Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells. Ishida A; Sasaguri T; Kosaka C; Nojima H; Ogata J J Biol Chem; 1997 Apr; 272(15):10050-7. PubMed ID: 9092548 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Tanner FC; Meier P; Greutert H; Champion C; Nabel EG; Lüscher TF Circulation; 2000 Apr; 101(16):1982-9. PubMed ID: 10779466 [TBL] [Abstract][Full Text] [Related]
5. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Wei GL; Krasinski K; Kearney M; Isner JM; Walsh K; Andrés V Circ Res; 1997 Mar; 80(3):418-26. PubMed ID: 9048663 [TBL] [Abstract][Full Text] [Related]
6. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest. Strobeck MW; Fribourg AF; Puga A; Knudsen ES Oncogene; 2000 Apr; 19(15):1857-67. PubMed ID: 10773875 [TBL] [Abstract][Full Text] [Related]
7. The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2. Koyama H; Nishizawa Y; Hosoi M; Fukumoto S; Kogawa K; Shioi A; Morii H Circ Res; 1996 Oct; 79(4):757-64. PubMed ID: 8831499 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying maintenance of smooth muscle cell quiescence in rat aorta: role of the cyclin dependent kinases and their inhibitors. Izzard TD; Taylor C; Birkett SD; Jackson CL; Newby AC Cardiovasc Res; 2002 Jan; 53(1):242-52. PubMed ID: 11744034 [TBL] [Abstract][Full Text] [Related]
9. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex. Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Gong J; Ammanamanchi S; Ko TC; Brattain MG Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668 [TBL] [Abstract][Full Text] [Related]
11. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL; Buffolino P; Kopman C; Nathanson L Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260 [TBL] [Abstract][Full Text] [Related]
14. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle. Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332 [TBL] [Abstract][Full Text] [Related]
15. Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cells. Redmond EM; Cahill PA; Hodges R; Zhang S; Sitzmann JV J Cell Physiol; 1996 Mar; 166(3):469-79. PubMed ID: 8600150 [TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol 3-kinase inhibitors block aortic smooth muscle cell proliferation in mid-late G1 phase: effect on cyclin-dependent kinase 2 and the inhibitory protein p27KIP1. Bacqueville D; Casagrande F; Perret B; Chap H; Darbon JM; Breton-Douillon M Biochem Biophys Res Commun; 1998 Mar; 244(3):630-6. PubMed ID: 9535716 [TBL] [Abstract][Full Text] [Related]
17. Effect of nitric oxide-cGMP-dependent protein kinase activation on advanced glycation end-product-induced proliferation in renal fibroblasts. Huang JS; Chuang LY; Guh JY; Chen CJ; Yang YL; Chiang TA; Hung MY; Liao TN J Am Soc Nephrol; 2005 Aug; 16(8):2318-29. PubMed ID: 15958724 [TBL] [Abstract][Full Text] [Related]
18. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip). Chen WJ; Chang CY; Lin JK Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329 [TBL] [Abstract][Full Text] [Related]
19. p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Smith RC; Branellec D; Gorski DH; Guo K; Perlman H; Dedieu JF; Pastore C; Mahfoudi A; Denèfle P; Isner JM; Walsh K Genes Dev; 1997 Jul; 11(13):1674-89. PubMed ID: 9224717 [TBL] [Abstract][Full Text] [Related]
20. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells. Cereseto A; Washington Parks R; Rivadeneira E; Franchini G Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]